Latest news
06-01-2022 - BMWi Supports Innovation for Manufacturing and Development of Specialty Lipids
New national funding programme funds collaborative R&D projects in Germany that develop novel specialty lipids and other types of auxiliary materials for mRNA vaccines as well as improve current manufacturing processes.
Since 2020, Bundesministerium für Wirtschaft und Klimaschutz (BMWi - Federal Ministry for Economic Affairs and Climate Protection) operates investment and innovation funding programmes for the German healthcare sector that are targeted at the control and prevention of pandemics. As part of these funding programmes, BMWi now funds research and development projects with specialty lipids and other auxiliary materials for mRNA vaccines and other mRNA drugs. The programme also supports innovation for improved manufacturing capacities.
[...]